Inaugural Houston Methodist Neal Cancer Center GI Oncology Symposium - December 6, 2024

Houston, TX US
December 6, 2024

In-Person and Virtual attendance options are available. 

Presented by the Houston Methodist Dr. Mary and Ron Neal Cancer Center

This symposium will delve into the latest developments in managing gastrointestinal  cancers. It will feature expert presentations on advancements in immunotherapy, molecular diagnostics,  targeted therapies and new surgical techniques, . Participants will also explore key trends in transplant oncology and the role of precision medicine. Each session will offer insights into disease pathogenesis, risk factors, prevention strategies, and innovative treatments, including discussions on minimally invasive procedures, enhanced imaging, and blood-based biomarkers. The symposium will emphasize how these advancements improve patient outcomes and provide a comprehensive review of current and emerging management strategies for various gastrointestinal cancers.

FEES

REGISTRATION TYPEFEE
Houston Methodist EmployeesComplimentary
Physician (Private physician located within the Greater Houston Area)*$185
Physician (Private physician located outside the Greater Houston Area)Complimentary
Research Scientist Complimentary
Allied Health Care Professional / All OthersComplimentary
Resident / Fellow / Student Complimentary

* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.

Target Audience

This symposium is designed for physician scientists, practicing oncologists, hepatologists, transplant surgeons, physician assistants, advanced nurse practitioners, oncology nurses, gastroenterologists, residents, fellows, medical students, allied health care professionals, and clinical research associates. Attendees involved in hepatobiliary, pancreatic, neuroendocrine, colorectal, esophageal, and gastric cancer care will find valuable insights for advancing their practice and improving patient care.

Learning Objectives

At the conclusion of this activity, the learner should be able to:

  • Describe the epidemiology, risk factors, and prevention strategies for gastrointestinal cancers.
  • Review the pathogenesis, surveillance modalities, and underuse of screening for hepatocellular carcinoma (HCC), focusing on blood-based biomarkers and management of pre-liver cancer diseases.
  • Evaluate transplant-bridging approaches and the role of immunotherapy in both resectable and advanced hepatocellular carcinoma, as well as new developments in treating advanced cholangiocarcinoma.
  • Assess updates on operative strategies for early-stage hepatobiliary cancers and transplant oncology for hilar and intrahepatic cholangiocarcinoma.
  • Explain the latest advancements in molecular diagnostics, operative and perioperative approaches, and targeted therapies for pancreatic adenocarcinoma, low-/intermediate-grade neuroendocrine carcinoma, and colorectal cancers.
  • Discuss advancements in multidisciplinary approaches for managing esophageal and gastric cancers, as well as the role of precision medicine in unresectable gastrointestinal malignancies
Course summary
Available credit: 
  • 5.25 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 5.25 Attendance
Course opens: 
08/19/2024
Course expires: 
01/06/2025
Event starts: 
12/06/2024 - 8:30am CST
Event ends: 
12/06/2024 - 3:15pm CST
Cost:
$185.00

Houston Methodist (In-person and virtual attendance options available)
6670 Bertner Avenue
John F. Bookout Auditorium, 2nd Floor
Houston, TX 77030
United States

LIVE (in-person attendance) will be held in the Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030. 

Virtual information will be provided to registered learners at a later date. 

CHAIR
Maen Abdelrahim, MD, PhD, B Pharm

Section Chief of Gastrointestinal Medical Oncology
Houston Methodist Oncology Partners

Available Credit

  • 5.25 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 5.25 Attendance

Interested in exhibiting or sponsoring? Contact us for more information.

Price

Cost:
$185.00
Please login or register to take this course.

FEES

REGISTRATION TYPEFEE
Houston Methodist EmployeesComplimentary
Physician (Private physician located within the Greater Houston Area)*$170
Physician (Private physician located outside the Greater Houston Area)Complimentary
Research Scientist Complimentary
Allied Health Care Professional / All OthersComplimentary
Resident / Fellow / Student Complimentary

* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.